These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
46 related items for PubMed ID: 1338678
1. [Role of ACE in the gastric cytoprotection. Dopaminergic and peripheral alpha 2 adrenergic mechanisms]. Laudanno OM, Cesolari JA, Bedini OA, San Miguel P. Acta Gastroenterol Latinoam; 1992; 22(2):99-105. PubMed ID: 1338678 [Abstract] [Full Text] [Related]
2. [Molsidomine and nitric oxide in gastric cytoprotection]. Laudanno OM, Cesolari JA, San Miguel P. Acta Gastroenterol Latinoam; 1993; 23(2):65-9. PubMed ID: 8249529 [Abstract] [Full Text] [Related]
3. Gastric cytoprotection induced by prostaglandin-dopaminergic mechanism. Laudanno OM, Bedini OA, San Miguel P, Cesolari JA. Acta Gastroenterol Latinoam; 1987; 17(4):299-303. PubMed ID: 2905107 [Abstract] [Full Text] [Related]
7. [Cytoprotection of gastric mucosa induced by tripotassium-dicitrato bismuthate against ethanol stress. Dependent mechanisms of sulfhydryl, dopaminergic and endogenous prostaglandin]. Laudanno OM, Bodini OA, San Miguel P, Cesolari JA, Capdopon E. Acta Gastroenterol Latinoam; 1986; 16(1):33-8. PubMed ID: 3577618 [Abstract] [Full Text] [Related]
12. Antihypertensive mechanism of the dipeptide Val-Tyr in rat aorta. Vercruysse L, Morel N, Van Camp J, Szust J, Smagghe G. Peptides; 2008 Feb; 29(2):261-7. PubMed ID: 18221823 [Abstract] [Full Text] [Related]
14. Effect of angiotensin-converting enzyme inhibitors on the power spectrum of heart rate variability in post-myocardial infarction patients. Kontopoulos AG, Athyros VG, Papageorgiou AA, Skeberis VM, Basayiannis EC, Boudoulas H. Coron Artery Dis; 1997 Feb; 8(8-9):517-24. PubMed ID: 9431480 [Abstract] [Full Text] [Related]
15. [Role of protons and bicarbonate in adaptative gastric cytoprotection]. Laudanno OM, Cesolari JA, Bedini OA, San Miguel P. Acta Gastroenterol Latinoam; 1990 Feb; 20(2):89-92. PubMed ID: 2275313 [Abstract] [Full Text] [Related]
16. Transport of angiotensin-converting enzyme inhibitors by H+/peptide transporters revisited. Knütter I, Wollesky C, Kottra G, Hahn MG, Fischer W, Zebisch K, Neubert RH, Daniel H, Brandsch M. J Pharmacol Exp Ther; 2008 Nov; 327(2):432-41. PubMed ID: 18713951 [Abstract] [Full Text] [Related]
17. Enalapril and lisinopril in renovascular hypertension--antihypertensive and hormonal effects of two new angiotensin-converting-enzyme (ACE) inhibitors. A preliminary report. Karlberg BE, Fyhrquist F, Grönhagen-Riska C, Tikkanen I, Ohman KP. Scand J Urol Nephrol Suppl; 1984 Nov; 79():103-6. PubMed ID: 6089307 [Abstract] [Full Text] [Related]
20. Therapeutic resistance to angiotensin converting enzyme (ACE) inhibition is related to pharmacodynamic and -kinetic factors in 5/6 nephrectomized rats. Windt WA, van Dokkum RP, Kluppel CA, Jeronimus-Stratingh CM, Hut F, de Zeeuw D, Henning RH. Eur J Pharmacol; 2008 Feb 02; 580(1-2):231-40. PubMed ID: 18036585 [Abstract] [Full Text] [Related] Page: [Next] [New Search]